The Supreme Court is taking up the abortion pill
A series of rulings by the Supreme Court has restricted access to the drug Mifepristone, a medication typically used with misoprostol to bring about a medical abortion and to manage early miscarriage. The drug remains on the market, and any changes to the drug’s availability have been temporarily halted.
The First Major Decision Since Roe v. Wade
Now, the Supreme Court has agreed to take up a case clarifying what changes are actually going to be made. The case would mark the first major abortion decision since the high court overturned Roe v. Wade last year.
This case would also have broader implications for the authority of the FDA, potentially challenging the ability of other agencies to protect health and safety. This article from Northeastern Global News gives insight into this historic case, featuring input from Northeastern’s Wendy Parmet (Law, Public Policy and Urban Affairs) and Daniel Urman (Law).
Key Data and Case Overview
- Primary Drug: Mifepristone (used with misoprostol)
- Primary Usage: To bring about a medical abortion and to manage early miscarriage
- Market Status: Remains available; changes are temporarily halted
- Legal Context: First major decision since overturning Roe v. Wade
- Regulatory Impact: Potential challenge to the authority of the FDA and other health agencies